D-Wave Quantum: IonQ's Blowout Quarter Lifts the Stock 15% as Investors Weigh a Faster Solver Against a Fresh Lawsuit
Published on 11/06/2026 at 19:31 | Editorial boerse-global.de
D-Wave Quantum shares jumped 15% on Thursday, riding a sector-wide rally in quantum computing names after peer IonQ posted strong quarterly results. The move puts a sharper question in front of shareholders: can D-Wave convert its own technical progress into commercial traction, or is the stock simply borrowing momentum from a rival's success?
IonQ reported third-quarter revenue of $173.8 million and raised its 2026 revenue guidance to a range of $505 million to $515 million. That gave the whole industry a positive reference point. For a sustained re-rating of D-Wave, though, the company's own business development will matter more than sector sentiment — and the next hard data point arrives on November 10, when D-Wave reports third-quarter 2026 results before the market opens, with a webcast to follow.
A solver that works faster — in-house, at least
On Wednesday, D-Wave announced improvements to its hybrid Stride solver. In company-run benchmark tests, the upgraded version found better solutions within 15 seconds than the previous version managed in 120 seconds. That is a measurable performance gain under test conditions, and it could make the technology more attractive to corporate users — provided the advantage holds up on real customer workloads.
The company also introduced a training track for applied quantum optimization, addressing not just raw performance but the practical side of adoption. Whether those sessions actually help users implement the technology is the open question. Commercial uptake, rather than isolated benchmark speed, is the yardstick that counts.
Korea pact and a pharma win offer early proof points
Two customer-facing developments give the bull case something concrete to point to. On October 28, D-Wave and LG CNS signed a non-binding memorandum of understanding to pursue quantum optimization applications for enterprises in South Korea and international markets, targeting manufacturing, telecommunications, finance and retail. The same day, D-Wave reported that Shionogi took first place in the quality-of-life category of the NEDO Quantum Computing Challenge, a prize that includes ÂĄ40 million to support further quantum computing research in drug development.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
In the best case, the faster solver and the LG CNS collaboration reinforce each other: technical gains make applications easier to build, while the partnership could push adoption inside enterprises. A research award in pharma adds a visible use case. What investors still lack is evidence that any of this shows up in the financials.
The bear case: non-binding means non-binding
The counterargument starts with the early stage of the commercial story. The LG CNS agreement carries no binding commitment, so its economic weight depends entirely on whether the partners turn intentions into deployed applications. Until then, execution remains the key risk.
Stride's performance edge, likewise, only earns real weight in valuations once it is proven outside company-run tests. If commercial execution lags the technical progress, the share price could lean more heavily on shifting sector sentiment — and a serious downside scenario would be a widening gap between expectations and actual business results.
There is also a legal overhang. According to law firm Pomerantz, a securities class action was filed against D-Wave and certain executives on October 20 in the U.S. District Court for the Northern District of California. The deadline for motions to be appointed lead plaintiff was set at December 15.
Analyst sentiment carries its own caveat. Wedbush analyst Matt Bryson reaffirmed his buy rating on Wednesday but cut his price target to $30 from $37 — a still-positive stance paired with a lower valuation. That raises the bar for verifiable operating progress.
November 10 is the real test
Context matters here: D-Wave and other quantum computing stocks came under selling pressure on Wednesday, according to media reports, before Thursday's rebound. Against that backdrop, company-specific progress is what a forward-looking assessment should hinge on.
The November 10 report will let investors measure how D-Wave's own business is developing and whether the link between economic results and the promised technical improvements holds. If management can draw that connection convincingly, the technical progress supports the bullish case. If commercialization disappoints, the tailwind from a competitor's strong numbers will carry less weight — and the investment decision should rest on how credible D-Wave's own path from better technology to economic results appears.
Ad
D-Wave Quantum Stock: New Analysis - 6 November
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
